David Ballesteros
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David Ballesteros has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abdul Ansari
Department of Critical Care, Nanavati Max Super Speciality Hospital, Mumbai, India
1 shared publication Andrea C. Mantilla
Nephrology Department, San José University Hospital, Popayán, Cauca, Colombia
1 shared publicationAndrea Cristina Mantilla Villarreal
Nephrology Service, University Hospital San José, University of Cauca, Popayán, Colombia
1 shared publicationDaniel R. Santiago
Nephrology Department, San José University Hospital, Popayán, Cauca, Colombia
1 shared publication- Harriet Adamson
Medical Affairs Department, CytoSorbents Europe GmbH, Berlin, Germany
1 shared publication Isabel Saravia
Medical Department, Vantive, Bogotá, Colombia
1 shared publication
Latest Publications
- Open Access
- 12 May 2026
- Published by Springer Nature in Journal of Anesthesia, Analgesia and Critical Care
- Vol. 6 (1)
Impact of extracorporeal circuits on systemic drug levels — a scoping review
This scoping review explores the potential effects of various extracorporeal technologies on the clearance of commonly used drugs. Understanding these inte
- 12 May 2026
- Published by Springer Nature in Journal of Anesthesia, Analgesia and Critical Care
- Vol. 6 (1)
Open AccessImpact of extracorporeal circuits on systemic drug levels — a scoping review
This scoping review explores the potential effects of various extracorporeal technologies on the clearance of commonly used drugs. Understanding these inte
- Open Access
- 15 December 2025
- Published by Frontiers Media SA in Frontiers in Nephrology
- Vol. 5, 1628181
Use of oXiris® hemoadsorption in sepsis and acute kidney injury: a retrospective cohort study in a resource-limited Colombian ICU
Background: Septic shock with acute kidney injury (AKI) carries high mortality in resource-limited settings. The oXiris ® membrane enables continuous renal replacement therapy (CRRT) with endotoxin and cytokine adsorption, but data from low- and middle-income countries are scarce. Methods: We conducted a single-center retrospective cohort of adults with septic shock and KDIGO stage 2–3 AKI treated with CRRT using oXiris ® in a Colombian public tertiary hospital (January 2021–March 2023). The primary outcome was renal recovery, defined as dialysis independence at discharge. Secondary outcomes included in-hospital mortality, vasopressor trajectories and hemodynamics over 72 hours, intensive care unit (ICU) length of stay, and outcomes stratified by COVID-19 status. Results: Fifty patients were analyzed (median age 56.5 [IQR 46.0–66.0] years; 32% male); 21 (42%) had confirmed SARS-CoV-2 infection. Norepinephrine requirements fell from 0.303 to 0.000 µg/kg/min over 72 hours (p® -based CRRT was associated with rapid vasopressor de-escalation and clinically meaningful kidney recovery among survivors, but overall mortality remained high and severity-dependent. COVID-19 septic shock showed a distinct profile, with higher baseline severity, a trend toward higher mortality, and impaired renal recovery. These data support feasibility and safety of hemoadsorptive CRRT in constrained settings and justify prospective comparative evaluation.
- 15 December 2025
- Published by Frontiers Media SA in Frontiers in Nephrology
- Vol. 5, 1628181
Open AccessUse of oXiris® hemoadsorption in sepsis and acute kidney injury: a retrospective cohort study in a resource-limited Colombian ICU
Background: Septic shock with acute kidney injury (AKI) carries high mortality in resource-limited settings. The oXiris ® membrane enables continuous renal replacement therapy (CRRT) with endotoxin and cytokine adsorption, but data from low- and middle-income countries are scarce. Methods: We conducted a single-center retrospective cohort of adults with septic shock and KDIGO stage 2–3 AKI treated with CRRT using oXiris ® in a Colombian public tertiary hospital (January 2021–March 2023). The primary outcome was renal recovery, defined as dialysis independence at discharge. Secondary outcomes included in-hospital mortality, vasopressor trajectories and hemodynamics over 72 hours, intensive care unit (ICU) length of stay, and outcomes stratified by COVID-19 status. Results: Fifty patients were analyzed (median age 56.5 [IQR 46.0–66.0] years; 32% male); 21 (42%) had confirmed SARS-CoV-2 infection. Norepinephrine requirements fell from 0.303 to 0.000 µg/kg/min over 72 hours (p® -based CRRT was associated with rapid vasopressor de-escalation and clinically meaningful kidney recovery among survivors, but overall mortality remained high and severity-dependent. COVID-19 septic shock showed a distinct profile, with higher baseline severity, a trend toward higher mortality, and impaired renal recovery. These data support feasibility and safety of hemoadsorptive CRRT in constrained settings and justify prospective comparative evaluation.
- Open Access
- 6 November 2023
- Published by Elsevier in Toxicology Reports
- Vol. 11, 449-451
Hemoadsorption and continuous venovenous hemodiafiltration in the management of paraquat poisoning during pregnancy: A case report
- 6 November 2023
- Published by Elsevier in Toxicology Reports
- Vol. 11, 449-451
Open AccessHemoadsorption and continuous venovenous hemodiafiltration in the management of paraquat poisoning during pregnancy: A case report